Evaluation of La(XT), a novel lanthanide compound, in an OVX rat model of osteoporosis
Authors:
Open Access
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Bone Reports
- Vol. 14, 100753
Abstract
No abstract availableKeywords
Funding Information
- Saskatchewan Health Research Foundation
- Natural Sciences and Engineering Research Council of Canada
This publication has 62 references indexed in Scilit:
- Spatial distribution of the trace elements zinc, strontium and lead in human bone tissueBone, 2013
- Efficacy and safety of lanthanum carbonate on chronic kidney disease–mineral and bone disorder in dialysis patients: a systematic reviewBMC Nephrology, 2013
- In Vitro Bioequivalence Approach for a Locally Acting Gastrointestinal Drug: Lanthanum CarbonateMolecular Pharmaceutics, 2013
- Rabbit as an animal model for experimental researchDental Research Journal, 2012
- Long-term treatment with lanthanum carbonate reduces mineral and bone abnormalities in rats with chronic renal failureNephrology Dialysis Transplantation, 2010
- Normal Bone Anatomy and PhysiologyClinical Journal of the American Society of Nephrology, 2008
- Long-Term Efficacy and Safety Profile of Lanthanum Carbonate: Results for up to 6 Years of TreatmentNephron Clinical Practice, 2008
- A Model of the Kinetics of Lanthanum in Human??Bone, Using Data Collected during the Clinical Development of the Phosphate Binder Lanthanum CarbonateClinical Pharmacokinetics, 2008
- Clinical Pharmacokinetics of the Phosphate Binder Lanthanum CarbonateClinical Pharmacokinetics, 2008
- Localization of lanthanum in bone of chronic renal failure rats after oral dosing with lanthanum carbonateKidney International, 2005